dc.contributor.author | Çökem Arvas, Sema | |
dc.contributor.author | Sarici, Ahmet Murat | |
dc.contributor.author | Dikkaya, Funda | |
dc.contributor.author | Uçar, Didar | |
dc.contributor.author | Sultan, Pinar | |
dc.date.accessioned | 2021-03-04T10:34:43Z | |
dc.date.available | 2021-03-04T10:34:43Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Sultan P., Çökem Arvas S., Sarici A. M. , Uçar D., Dikkaya F., "Efficacy and safety of intra-vitreal Bevacizumab (Avastin®) using Pro Re Nata regimen in treatment of macular edema due to retinal vein occlusion Retina ven tikanikliǧina baǧli maküla ödemi tedavisinde pro re nata protokolünde intra-vitreal Bevacizumab (Avastin ®) tedavisinin etki ve yan etki profili", Retina-Vitreus, cilt.24, sa.4, ss.313-318, 2016 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_6df11ecb-9e43-477b-aae2-264b254256b1 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/75926 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066956455&origin=inward | |
dc.language.iso | eng | |
dc.title | Efficacy and safety of intra-vitreal Bevacizumab (Avastin®) using Pro Re Nata regimen in treatment of macular edema due to retinal vein occlusion Retina ven tikanikliǧina baǧli maküla ödemi tedavisinde pro re nata protokolünde intra-vitreal Bevacizumab (Avastin ®) tedavisinin etki ve yan etki profili | |
dc.type | Makale | |
dc.relation.journal | Retina-Vitreus | |
dc.contributor.department | T. C. Sağlık Bakanlığı, Taksim Eğitim ve Araştirma Hastanesi , , | |
dc.identifier.volume | 24 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 313 | |
dc.identifier.endpage | 318 | |
dc.contributor.firstauthorID | 1042530 | |